We provide you with 20 years of free, institutional-grade data for MGX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MGX. Explore the full financial landscape of MGX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about MGX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Metagenomi Inc.(NASDAQ:MGX) 
Metagenomi, Inc., a gene editing biotechnology company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company is headquartered in Emeryville, California.
Website: https://metagenomi.co/
Founded: 2018
CEO / Founder: Brian C. Thomas
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends